Oct 8, 2021
State Medicaid programs are required to cover all drugs approved by the US Food & Drug Administration (FDA), including those that have received accelerated approval from the FDA to treat serious or life-threatening illnesses such as HIV or cancer. These drugs with accelerated approval may be beneficial based...
Sep 3, 2021
We know that the pandemic caused millions of people to lose their jobs, and potentially their job-based insurance, and yet new survey data showed surprisingly small changes in uninsurance rates at the end of 2020. Kate Bundorf, PhD, from the Sanford School of Public Policy at Duke University and Jessica Banthin, PhD, of...
Aug 6, 2021
Firearms are the most common method of suicide in the US over the past decade. Primary care and mental health clinicians frequently interact with individuals at risk for suicide, but clinicians are often unaware of whether these patients have access to firearms. Julie Richards, PhD, from the Kaiser Permanente Washington...
Jul 2, 2021
The COVID-19 pandemic has had far-reaching effects on the use of health care services. Dr Nora Becker of the University of Michigan talks about her research on reductions in the use of women’s preventive health services, and JAMA Health Forum Editors Dr John Ayanian and Dr Melinda Buntin discuss other JAMA...
Jun 4, 2021
Participating in value-based incentive programs imposes financial and time costs on physician practices. Dhruv Khullar of Weill Cornell Medical College and Jason Hockenberry of Yale School of Public Health discuss these burdens, the challenge of quality measurement, and ways increase the “value” of value-based...